Issue 38, 2011

Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(ii) complexes. Syntheses, biological activity and XAS studies

Abstract

New nitroimidazole and glucosamine conjugated heteroscorpionate ligands, namely 2,2-bis(3,5-dimethyl-1H-pyrazol-1-yl)-N-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl)acetamide (LMN) and 1,3,4,6-tetra-O-acetyl-2-{[bis(3,5-dimethyl-1H-pyrazol-1-yl)acetyl]amino}-2-deoxy-β-D-glucopyranose (LDAC), respectively, were synthesized by direct coupling of preformed side chain acid and amine components. The related copper(II) complexes {[(LMN)2Cu]Cl2}, and {[(LDAC)2Cu]Cl2} have been prepared from the reaction of CuCl2*2H2O with LMN or LDAC ligand in methanol solution. Single crystal structural characterization was undertaken for the LMN ligand. In the absence of a coordinated metal core, the overall arrangement of the ligand is determined by some loose intra- and inter-molecular nonbonding contacts. X-Ray Absorption Spectroscopy (XAS) has been used to probe the local structure of the two copper(II) complexes, {[(LMN)2Cu]Cl2} and {[(LDAC)2Cu]Cl2}. The EXAFS analysis has permitted the identification of the local environment of the copper site. Copper interacts with 2 units of ligand in both complexes, and it is found to be 6-fold coordinated. Its local structure is described by four Cu–N and two Cu–O interactions to form a pseudo-octahedron core, with a 0.14 Å lengthening of the Cu–O bond length in the case of LDAC complex with respect to the LMN one, likely due to the higher steric hindrance of the glucosamine moiety. The XANES analysis agrees with these results, also confirming the Cu(II) formal copper oxidation state for both complexes. The new copper(II) complexes {[(LMN)2Cu]Cl2} and {[(LDAC)2Cu]Cl2} as well as the corresponding uncoordinated ligands were evaluated for their cytotoxic activity towards a panel of several human tumour cell lines. The results reported here indicate that both copper(II) complexes show similar spectra of cytotoxicity and very low resistance factors (RF < 2) against C13* ovarian cancer cells which have acquired resistance to cisplatin.

Graphical abstract: Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(ii) complexes. Syntheses, biological activity and XAS studies

Supplementary files

Article information

Article type
Paper
Submitted
22 Mar 2011
Accepted
11 May 2011
First published
28 Jun 2011

Dalton Trans., 2011,40, 9877-9888

Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies

M. Pellei, G. Papini, A. Trasatti, M. Giorgetti, D. Tonelli, M. Minicucci, C. Marzano, V. Gandin, G. Aquilanti, A. Dolmella and C. Santini, Dalton Trans., 2011, 40, 9877 DOI: 10.1039/C1DT10486A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements